Search

Body temperature is a crucial indicator in assessing human physiological activity and health, particularly in pediatric and critically ill patients. This study aimed to compare temperature recordings obtained from digital calibrated thermometers with calibrated infrared thermometers and non‑calibrated infrared thermometers against calibrated ones. An observational prospective study was conducted at AIIMS Bhopal, involving volunteers and febrile patients who consented to participate. Approval was obtained from the Institutional Human Ethics Committee, and 200 participants meeting inclusion/exclusion criteria were included. Data were collected and analyzed using Microsoft Excel. Mean and variance values were computed for both volunteer and febrile patient groups. The P values in both groups were less than 0.05, indicating a significant difference between non‑calibrated handheld infrared thermometers (T1), calibrated digital thermometers (T2), and their individual comparison with calibrated infrared thermometers (T3). Variance was higher in non‑calibrated infrared thermometers (T1) compared to calibrated ones (T2) in both healthy volunteers and febrile patients. Pearson’s correlation coefficient analysis within the febrile patient group demonstrated a robust positive correlation among all three thermometers compared to the healthy volunteers group. The study highlights variations in temperature readings when using different thermometers, irrespective of whether the assessment is conducted on healthy volunteers or febrile patients. Notably, the strength of association is lower in healthy volunteers than in febrile patients, suggesting that the interchangeability of thermometers may be more reliable and sufficient when assessing individuals with fever. These findings underscore the importance of careful consideration and validation of thermometer choices, especially in clinical settings where accurate temperature measurement is critical. [ABSTRACT FROM AUTHOR]

Background The intensive care unit (ICU) represents an important platform for conducting drug utilization analysis using defined daily dose (DDD)/100 bed-days and the financial burden of treatment as patients are seriously ill and are often suffering from chronic critical illnesses. Therefore, in this study, we evaluated the drug utilization patterns and cost of treatment in the ICU. Methods A retrospective observational analysis of the medical records obtained for the medical ICU of an apex tertiary care teaching hospital in central India was conducted for a period of three years from 2017 to 2019. All the patients admitted to the medical ICU during the study tenure were included in the study. Patients hospitalized in neonatal intensive care unit (NICU), pediatric intensive care unit (PICU), and surgical ICU were excluded from the study. The socio-demographic and clinical data, utilization of different classes of drugs, WHO-Anatomic Therapeutic Chemical (WHO-ATC) classification, DDD/100 bed days, hospital stay, etc. were analyzed. A partial pharmaco-economic analysis of the average cost of admission to patients was done. Results Data from 280 patients was assessed. The mean age was 47 ± 19.18 years and 58% were males. Antibiotics and injections were prescribed to 96% and 97.5% of the patients, respectively, during their ICU stay (median: seven days). Antimicrobial drugs were most frequently prescribed (n=1096, 68%); the most common were beta-lactams and carbapenems, followed by drugs acting on the central nervous system (5%) and cardiovascular system (4.3%). Cefoperazone/sulbactum, ceftriaxone, and piperacillin/tazobactam were the most utilized antibiotics with 8, 16, and 6 DDD/100 bed-days, respectively, while proton pump inhibitors, analgesics, and anti-epileptics were the most frequently prescribed non-antimicrobial drug class. The median cost of treatment per ICU admission was Indian Rupees (INR) 23,347 (IQR 12,552- 65,524). Conclusion Drug utilization assessment provides crucial information for understanding the usage of drugs in the settings of the ICU, and should be conducted regularly to help in the proper planning and implementation of rational drug use. Treatment costs reflect the high economic burden seen in ICU admissions., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Atal et al.)